Pyribencarb

Pyribencarb

SCHEMBL557599

COC(=O)NCc1cc(/C(C)=N/OCc2cccc(C)n2)ccc1Cl.NC(=O)O

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
PPARG P37231 5/20 0.38
PPARA Q07869 4/20 0.38
MEN1 O00255 1/20 0.36
OPRM1 P35372 1/20 0.36
OPRD1 P41143 1/20 0.36
KMT2A Q03164 1/20 0.36
ADORA2A P29274 1/20 0.35
DPP4 P27487 1/20 0.35
PTGES O14684 1/20 0.34
HPGD P15428 1/20 0.34
CD38 P28907 1/20 0.34
TSHR P16473 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 1/20 0.34
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
PPARD Q03181 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyribencarb SCHEMBL3228377 0.96 NPC1 (0.39) NPC1RAB9APPARGPPARAMEN1
Pyribencarb SCHEMBL18875 0.96 NPC1 (0.39) NPC1RAB9APPARGPPARAMEN1
Pyribencarb SCHEMBL29935941 0.96 NPC1 (0.39) NPC1RAB9APPARGPPARAMEN1
Pyribencarb SCHEMBL557610 0.96 NPC1 (0.39) NPC1RAB9APPARGPPARAMEN1
SCHEMBL2778024 0.92 NPC1 (0.41) NPC1RAB9APPARGPPARAMEN1
SCHEMBL2744761 0.92 NPC1 (0.41) NPC1RAB9APPARGPPARAMEN1
SCHEMBL2744757 0.92 NPC1 (0.41) NPC1RAB9APPARGPPARAMEN1
SCHEMBL4667786 0.90 NPSR1 (0.40) NPC1RAB9APPARGPPARAMEN1
SCHEMBL4667781 0.90 NPSR1 (0.40) NPC1RAB9APPARGPPARAMEN1
SCHEMBL4622925 0.88 MEN1 (0.36) NPC1RAB9APPARGPPARAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166109-A1 Synergistic Active Compound Combinations Comprising Phenyltriazoles BAYER CROPSCIENCE AG (DE) 2011-07-07 US claimed
US-9012360-B2 Synergistic combinations of active ingredients BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-21 US disclosed
US-20120035050-A1 Synergistic Combinations Of Active Ingredients BAYER CROPSCIENCE AG (DE) 2012-02-09 US disclosed
US-20110166109-A1 Synergistic Active Compound Combinations Comprising Phenyltriazoles BAYER CROPSCIENCE AG (DE) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035050-A1 Synergistic Combinations Of Active Ingredients C1S, MAN2B1, MANBA NPC1 1026/4885RAB9A 513/4885PPARG 4292/4885
US-20110166109-A1 Synergistic Active Compound Combinations Comprising Phenyltriazoles NAT1, ACAT1, CAT NPC1 1734/4885RAB9A 3686/4885PPARG 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.